Abstract
Purpose
The purpose of this study was to elucidate our experience in the diagnosis and treatment of adenoid cystic carcinoma of the vulva (ACC-vulva) and to assess the clinicopathological characteristics and prognosis among ACC-vulva patients.
Methods
A retrospective study of seventeen patients was performed to illustrate the demographic information, clinical performance, pathological characteristics, treatment modality, and development of local recurrence or distant metastasis, as well as the survival outcome.
Results
The median age at diagnosis was 56 years (range, 26–71 years). Radical local excision was performed on fifteen patients, and two patient received radical hemi-vulvectomy. Six patients received ipsilateral inguinal lymphadenectomy. Involvement of the resection margin was observed in six patients. The postoperative pathologic diagnosis showed no proof of inguinal lymph node metastasis in all the six patients receiving lymphadenectomy. However, the perineural invasion was observed in all patients. Postoperative adjuvant radiotherapy was applied to five patients who had positive resection margin. The mean survival time except for that in four patients (recent case) was 47.8 months (range, 23–78 months).
Conclusion
Radical resection towards negative margins seems to be acceptable as initial treatment. Adjuvant radiotherapy is a preferable treatment modality for patients with high-risk factors pathologically or patients with local recurrence.
Similar content being viewed by others
Availability of data and material
All data generated or used during the study appear in the submitted article.
References
Yang SY, Lee JW, Kim WS et al (2006) Adenoid cystic carcinoma of the Bartholin’s gland: report of two cases and review of the literature. Gynecol Oncol 100(2):422–425
Alsan CI, Vinh-Hung V, Eren F et al (2011) Adenoid cystic carcinoma of the Bartholin’s gland: case report and systematic review of the literature. Eur J Gynaecol Oncol 32(5):567–572
Sisodia SM, Khan WA, Ansari SA et al (2013) Adenoid cystic carcinoma of Bartholin’s gland: Report of a case and review of literature. South Asian J Cancer 2(1):18
Hou JL, Wu LY, Zhang HT et al (2010) Clinicopathological characteristics of six patients with adenoid cystic carcinoma of the Bartholin gland. Zhonghua Zhong Liu Za Zhi 32(4):290–293
Li J, Cai Y, Ke G et al (2015) Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population. Gynecol Oncol 137(2):274–279
Xing D, Schoolmeester JK, Ren Z et al (2016) Lower female genital tract tumors with adenoid cystic differentiation: p16 expression and high-risk HPV detection. Am J Surg Pathol 40(4):529–536
Brill LB 2nd, Kanner WA, Fehr A et al (2011) Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol 24(9):1169–1176
Persson M, Andren Y, Mark J et al (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 106(44):18740–18744
Xing D, Bakhsh S, Melnyk N et al (2017) Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva. Int J Gynecol Pathol 36(3):289–293
Mitani Y, Li J, Rao PH et al (2010) Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin Cancer Res 16(19):4722–4731
Andersson MK, Mangiapane G, Nevado PT et al (2020) ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma. Oncogenesis 9(1):5
Lelle RJ, Davis KP, Roberts JA (1994) Adenoid cystic carcinoma of the Bartholin’s gland: the University of Michigan experience. Int J Gynecol Cancer 4(3):145–149
Nasu K, Kawano Y, Takai N et al (2005) Adenoid cystic carcinoma of Bartholin’s Gland. Case report with review of the literature. Gynecol Obstet Invest 59(1):54–58
Copeland LJ, Sneige N, Gershenson DM et al (1986) Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol 67(1):115–120
Papaspyrou G, Hoch S, Rinaldo A et al (2011) Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review. Head Neck 33(6):905–911
Coca-Pelaz A, Rodrigo JP, Bradley PJ et al (2015) Adenoid cystic carcinoma of the head and neck–An update. Oral Oncol 51(7):652–661
Hitre E, Budai B, Takacsi-Nagy Z et al (2013) Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial. Br J Cancer 109(5):1117–1122
Chang Y, Wu W, Chen H: Adenoid cystic carcinoma of the Bartholin’s gland: a case report and literature review. J Int Med Res 2019:300060519863540
Yoon G, Kim HS, Lee YY et al (2015) Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands. Int J Clin Exp Pathol 8(5):5688–5694
Rosenberg P, Simonsen E, Risberg B (1989) Adenoid cystic carcinoma of Bartholin’s gland: a report of five new cases treated with surgery and radiotherapy. Gynecol Oncol 34(2):145–147
Lopez-Varela E, Oliva E, McIntyre JF et al (2007) Primary treatment of Bartholin’s gland carcinoma with radiation and chemoradiation: a report on ten consecutive cases. Int J Gynecol Cancer 17(3):661–667
Wheelock JB, Goplerud DR, Dunn LJ et al (1984) Primary carcinoma of the Bartholin gland: a report of ten cases. Obstet Gynecol 63(6):820–824
Min R, Siyi L, Wenjun Y et al (2012) Salivary gland adenoid cystic carcinoma with cervical lymph node metastasis: a preliminary study of 62 cases. Int J Oral Maxillofac Surg 41(8):952–957
Woida FM, Ribeiro-Silva A (2007) Adenoid cystic carcinoma of the Bartholin gland: an overview. Arch Pathol Lab Med 131(5):796–798
Milchgrub S, Wiley EL, Vuitch F et al (1994) The tubular variant of adenoid cystic carcinoma of the Bartholin’s gland. Am J Clin Pathol 101(2):204–208
Ramanah R, Allam-Ndoul E, Baeza C et al (2013) Brain and lung metastasis of Bartholin’s gland adenoid cystic carcinoma: a case report. J Med Case Rep 7:208
Acknowledgements
We’d like to show our sincere gratitude to all the faculty members in our department and all the patients and their families involved in the current study.
Author information
Authors and Affiliations
Contributions
JZ, GK: Protocol development. JZ, LY: Data collection or management. JZ: Data analysis. JZ, LY, QW, XW & GK: Manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhu, J., Yin, L., Wang, Q. et al. Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience. Int J Clin Oncol 25, 2144–2150 (2020). https://doi.org/10.1007/s10147-020-01764-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-020-01764-0